Expression of Ki 67 in hepatocellular carcinoma induced by diethylnitrosamine in mice and its correlation with histopathological alterations

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 3, 2012, Pages 52-59

  Youssef, Magda Ismail ^a   Maghraby, Hala ^a   Youssef, Eman Ahmed ^a   El Sayed, Mohammed Mahmoud ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

DEN; HCC; Histopathology and immunohistochemistry; Ki 67

Indexed keywords

EID: 84875909501     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001; 5(2): 315-334.
2. Al-Rejaie SS, Alisa AM, Al-Yahya AA, Bakheet SA, Alsheikh A, Fatani AG, Al-Shabanah OA, Sayed-Ahmed MM. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol. 2009; 15 (11): 1373-1380.
3. Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, Yasui Y, Hosokawa T, Ueda K, Kuzuya T. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology (Baltimore, Md) 2010; 52(2):518-527.
4. Bancroft JD, Stevens A: Theory and Practice of Histological Technique.4th Ed., Churchill livingstone, Edinburg, New York. 2002; pp 116-117.
5. Barbareschi, M., Girlando, S., Mauri, F. M., Forti, S., Eccher, C., Mauri, F. A., Togni, R., Dalla Palma, P., and Doglioni, C. Quantitative growth fraction evaluation with MIBI and Ki67 antibodies in breast carcinomas. Am J Clin Pathol. 1994; 102: 171-175.
6. Bubendorf L, Tapia C, Gasser TC, Casella R, Grunder B, Moch H, Mihatsch MJ, Sauter G: Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. Hum Pathol. 1998; 29: 949-954.
7. Chattopadhyay MB, Mukherjee S, Kulkarni I, VijayanV, Doloi M, Kanjilal NB and Chatterjee M. Proton-induced X-ray emission (PIXE) analysis and DNA-chain break study in rat hepatocarcinogenesis: A possible chemopreventive role by combined supplementation of vanadium and beta-carotene. Cancer Cell International. 2005, 5:16-24.
8. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatol. 2005; 41(4):809-818.
9. De-Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De-Vries EG.: Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatol. 1998; 28: 971-979.
10. De Riese, W. T., Crabtree, W., Allhoff, E., Werner, M., Liedke, S., Lenis, G., Atzpodien, J., and Kirchner, H. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncol. 1993; 11: 1804-1808.
11. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterol. 2007; 132(7): 2557-2576.
12. Faratian D, Munro A, Twelves C, Bartlett JM. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology. 2009; 54(1): 254-257.
13. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis. 1999; 19: 243-252.
14. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA, Zheng SS, Sarin S, Hamid S, Modawi SB, Fleig W, Fedail S, Thomson A, Khan A, Malfertheiner P, Lau G, Carillo FJ, Krabshuis J, Le Mair A; World Gastroenterology Organisation Guidelines and Publications Committee. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis. 2010;19(3):311-317.
15. Gang Z, Qi Q, Jing C, Wang C,. Measuring Microenvironment mechanical stress of rat liver during diethylnitrosamine induced hepatocarcinogenesis by atomic force microscope. Microsc Res Tech. 2009; 72(9):672-678.
16. George J, Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol. 1996; 28(3): 353-361.
17. Graflund M, Sorbe B, Karlsson M: MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome. Int J Oncol. 2002; 20: 1041-1047.
18. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis.2006; 15(2):149-159.
19. Guzman G, Alagiozian-Angelova V, Layden-Almer JE, Layden TJ, Testa G, Benedetti E, Kajdacsy-Balla A, Cotler SJ. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Modern Pathology. 2005; 18, 1498-1503.
20. Horiguchi N, Ishac EJ, Gao B: Liver regeneration is suppressed in alcoholic cirrhosis: Correlation with decreased STAT3 activation. Alcohol. 2007; 41(4):271-280.
21. Ito Y, Matsuura N, Sakon M, Takeda T, Umeshita K., Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Naka K, Monden M. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer 1999; 81(4): 747-751.
22. Kiernan JA: Histological and Histochemical methods: Theory and practice 3rd ed. Arnold Euston Road, London. 2001; pp154-155.
23. Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. J Viral Hepat.2005; 12(6): 635-641.
24. Kweon S, Park KA, Choi H: Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis. Life Sci. 2003; 73: 2515-2526.
25. Liao DJ, Blanck A, Eneroth P, Gustafsson JÅ, Hällström IP: Diethylnitrosamine causes pituitary damage, disturbs hormone levels, and reduces sexual dimorphism of certain liver functions in the rat. Environ Health Perspect. 2001; 109 (9): 943-947.
26. Li X, Shi ZM, Fing P, Wen ZY, Wang XJ. Effect of Qiprotecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis. World J Gastroenterol. 2007; 13: 4192-4198.
27. Lin GY, Chen ZL, Lu CM, Li Y, Ping XJ, Huang R Immunohistochemical stud y on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol. 2000; 6(2): 234-238.
28. Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF beta signaling pathway in hepatic fibrosis. Liver Int. 2006; 26(1):8-22.
29. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology (Baltimore, Md) 2008; 48(4):1312-1327.
30. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362(9399):1907-1917.
31. Lunz JG 3rd, Tsuji H, Nozaki I, Murase N, Demetris AJ An inhibitor of cyclin-dependent kinase, stress-induced p21(Waf-1/Cip-1), mediates hepatocyte mito-inhibition during the evolution of cirrhosis. Hepatol 2005; 41(6):1262-1271.
32. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IK K beta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 2005; 121(7): 977-990.
33. Martin B, Paesmans M, Mascaux C, Berghmans T, Lothaire P, Meert AP, Lafitte JJ, Sculier JP: Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer. 2004; 91: 2018-2025.
34. Mathieu MC: The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer. 2004; 40: 342-351.
35. Mazen A. Ghanem, Theo H. Van der Kwast, Mondastri K. Sudaryo, Rejiv B. Mathoera, Marry M. van den Heuvel, Abdel-Alim M. Al-Doray, Rien M. Nijman, and Gert J. van Steenbrugge. MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1Protein Expression in Nephroblastoma. Clinical Cancer Research 2004; 10: 591-597.
36. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology.1999; 117(3):669-677.
37. Ojanguren I, Ariza A, Llatjos M, Castellá E, Mate JI, Navas-Palacios: Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration. Human Pathol. 1993; 24: 905-908.
38. Oshi S, Ken H, Masato I, Yasushi T, Michiko O, Shunsuke K, Hisao I, Hironaka K: Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. Carcinogenesis.1999; 20: 59-63.
39. Pizem J, Marolt VF, Luzar B, Cor A. Proliferative and apoptotic activity in hepatocellular carcinoma and surrounding nonneoplastic liver tissue Pflugers Arch. 2001; 442(6): 174-176.
40. Poirier MC, Beland FA: DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents. Environ Health Perspect. 1994; 102: 161-165.
41. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002; 8: 385-392.
42. Ramakrishnan G, Raghavendran HR, Vinodhkumar R, Devaki T: Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem Biol Interact. 2006; 161: 104-114.
43. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Haussinger D. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 2005; 129: 2009-2031.
44. Sadik NA, El-Maraghy SA, Ismail MF. Diethylnitrosamineinduced hepatocarcinogenesis in rats: possible chemoprevention by blueberries. African Journal of Biochemistry. 2008; 2(3): 81-87.
45. Saffhill R, Margison GP, O'Connor PJ: Mechanisms of carcinogenesis induced by alkylating agents. Biochem Biophys Acta. 1985; 823: 111-145.
46. Schmitt F. C. L., Estevao D., Kobayasi S., Curi P. and Camargo J. L. V. Altered foci of hepatocytes in rats initiated with diethylnitrosamine after prolonged fasting. Food and Chemical Toxicology. 1993; 31: 629-636.
47. Scholzen T, Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182: 311-322.
48. Sivaramakrishnan V, Shilpa PN, Praveen-Kumar VR, Niranjali-Devaraj S: Attenuation of N-nitrosodiethylamine induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact. 2008; 171: 79-88.
49. Stanton KJ, Sidner RA, Miller GA: Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas Am J Surg. 2003; 186: 486-492.
50. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C. Marumo F. Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol. 1991; 164 (3), 273-278.
51. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni: Development of hepatocellular carcinoma associated increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology. 1992; 103: 595-600.
52. Umemura, T, Kai S, Hasegawa R, Keita K, Kitamura Y, Nishikawa A, Hirose M Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamineinduced hepato-and cholangio carcinogenesis in mice by green teainfusion. Carcinogenesis, 2003; 24(6): 1105-1109.
53. Verna L, Whysner J, Williams GM: N-nitrosodiethylamine mechanistic data and risk asseessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther. 1994; 71: 57-58.
54. Yadav AS, Bhatnagar D: Chemo-preventive effect of star anise in N-nitrosodiethylamine initiated and phenobarbital promoted hepatocarcinogenesis. Chem Biol Interact. 2007; 169: 207-214.
55. Yeh TS, Chen TC, Chen MF. Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression. Arch Surg. 2000; 135(11):1334-1339.